4.01Open4.01Pre Close0 Volume0 Open Interest1.00Strike Price0.00Turnover0.00%IV0.36%PremiumMay 17, 2024Expiry Date4.48Intrinsic Value100Multiplier-2DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma1.22Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Vanda Pharmaceuticals Stock Discussion
Vanda Pharmaceuticals: 2Nd Phase III Study Showed Tradipitant Is Effective in Prevention of Vomiting Associated With Motion Sickness
We found a bold and calculated maneuver, Future Pak LLC ("Future Pak") has stepped up its acquisition game by enhancing its offer for Vanda Pharmaceuticals Inc. ("Vanda" or "the Company"), signaling a pivotal moment in the pharmaceutical industry's mergers and acquisitions landscape. This revised proposal not only raises the cash consideration but notably...
Future Pak Increases Bid For Vanda Pharmaceuticals To Include CVRs In Addition To $7.25-$7.75 Per Share In Cash; Offer Represents $11.62-$12.12 Per Share
looking for it to move ip and test morning highs
No comment yet